The emergence of the coronavirus variant which was detected in South Africa brought much panic to people and experts.
The variant was found to be more contagious than the original virus. The coronavirus vaccine which was imported in South Africa from the India, the astrazaneca vaccine was halted post studies which proved that it's less effective to the coronavirus variant.
However some good news about the coronavirus variant, South African scientist have discovered out people who were infected by the new variant of the coronavirus developed antibodies against re-infection.
But it's not clear at this time how long the immunity last. The immunity against the non variant coronavirus lasted for about 8 month as reported in the article by WebMD. However whether patients who recover are safe from re-infection is not clear.
South Africa is using the Johnson and Johnson coronavirus vaccine which is effective with immunity against coronavirus.
Thank you for reading,
Content created and supplied by: Technon (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More